Enfortumab Vedotin-induced Hyperglycemia and Ileal Conduit Reconstruction-induced Metabolic Acidosis

We report a 76-year-old man who was treated for hyperglycemia and metabolic acidosis after chemotherapy with enfortumab vedotin and pembrolizumab administered after his surgery for bladder cancer. He had an approximately 20-year history of diabetes. His body mass index was 18.6, and he received metf...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Takaaki, Suzuki, Hiroshi, Asashima, Yuya, Sone, Hirohito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580417/
https://www.ncbi.nlm.nih.gov/pubmed/37909003
http://dx.doi.org/10.1210/jcemcr/luad092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580417/
https://www.ncbi.nlm.nih.gov/pubmed/37909003
http://dx.doi.org/10.1210/jcemcr/luad092

Ejemplares similares